NO20030115D0 - Kontrastmiddel - Google Patents

Kontrastmiddel

Info

Publication number
NO20030115D0
NO20030115D0 NO20030115A NO20030115A NO20030115D0 NO 20030115 D0 NO20030115 D0 NO 20030115D0 NO 20030115 A NO20030115 A NO 20030115A NO 20030115 A NO20030115 A NO 20030115A NO 20030115 D0 NO20030115 D0 NO 20030115D0
Authority
NO
Norway
Prior art keywords
imaging agents
formula
moiety
angiotensin
affinity
Prior art date
Application number
NO20030115A
Other languages
English (en)
Inventor
Magne Solbakken
Original Assignee
Amersham Health As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Amersham Health As filed Critical Amersham Health As
Priority to NO20030115A priority Critical patent/NO20030115D0/no
Publication of NO20030115D0 publication Critical patent/NO20030115D0/no
Priority to CNA2004800019549A priority patent/CN1723043A/zh
Priority to PCT/NO2004/000002 priority patent/WO2004062568A2/en
Priority to JP2006500737A priority patent/JP2006517539A/ja
Priority to US10/541,949 priority patent/US7919071B2/en
Priority to AT04701136T priority patent/ATE425770T1/de
Priority to DE602004020049T priority patent/DE602004020049D1/de
Priority to EP04701136A priority patent/EP1581262B1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0819—Tripeptides with the first amino acid being acidic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/0002—General or multifunctional contrast agents, e.g. chelated agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/0497—Organic compounds conjugates with a carrier being an organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/10—Spiro-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Physics & Mathematics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Optics & Photonics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Magnetic Resonance Imaging Apparatus (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Ultra Sonic Daignosis Equipment (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Light Receiving Elements (AREA)
  • Steroid Compounds (AREA)
NO20030115A 2003-01-09 2003-01-09 Kontrastmiddel NO20030115D0 (no)

Priority Applications (8)

Application Number Priority Date Filing Date Title
NO20030115A NO20030115D0 (no) 2003-01-09 2003-01-09 Kontrastmiddel
CNA2004800019549A CN1723043A (zh) 2003-01-09 2004-01-09 造影剂
PCT/NO2004/000002 WO2004062568A2 (en) 2003-01-09 2004-01-09 Conjugate of losartan, valsartan, candesartan or eprosartan and a chelant as contrast agent
JP2006500737A JP2006517539A (ja) 2003-01-09 2004-01-09 造影剤
US10/541,949 US7919071B2 (en) 2003-01-09 2004-01-09 Contrast agent
AT04701136T ATE425770T1 (de) 2003-01-09 2004-01-09 Kontrastmittel
DE602004020049T DE602004020049D1 (de) 2003-01-09 2004-01-09 Kontrastmittel
EP04701136A EP1581262B1 (en) 2003-01-09 2004-01-09 Contrast agent

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
NO20030115A NO20030115D0 (no) 2003-01-09 2003-01-09 Kontrastmiddel

Publications (1)

Publication Number Publication Date
NO20030115D0 true NO20030115D0 (no) 2003-01-09

Family

ID=19914362

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20030115A NO20030115D0 (no) 2003-01-09 2003-01-09 Kontrastmiddel

Country Status (8)

Country Link
US (1) US7919071B2 (no)
EP (1) EP1581262B1 (no)
JP (1) JP2006517539A (no)
CN (1) CN1723043A (no)
AT (1) ATE425770T1 (no)
DE (1) DE602004020049D1 (no)
NO (1) NO20030115D0 (no)
WO (1) WO2004062568A2 (no)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO20034350D0 (no) * 2003-09-29 2003-09-29 Amersham Health As Optisk avbilding av kolorektal kreft
US7431914B2 (en) 2003-11-24 2008-10-07 Ge Healthcare As Contrast agent
EP1729823B1 (en) * 2004-03-04 2009-11-04 GE Healthcare AS Conjugates of angiotensin peptidic analogues and chelating agents for diagnosis and therapy
FR2902428B1 (fr) * 2006-06-15 2008-08-15 Servier Lab Nouveaux derives diazeniumdiolates, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
WO2008058551A1 (en) * 2006-11-13 2008-05-22 Telefonaktiebolaget L M Ericsson (Publ) Wireless telecommunications systems
EP2101826B1 (en) * 2006-12-11 2010-06-23 GE Healthcare AS Radiolabelled peptide based compounds and uses thereof
TW201215388A (en) * 2010-07-05 2012-04-16 Sanofi Sa (2-aryloxyacetylamino)phenylpropionic acid derivatives, processes for preparation thereof and use thereof as medicaments
TW201215387A (en) 2010-07-05 2012-04-16 Sanofi Aventis Spirocyclically substituted 1,3-propane dioxide derivatives, processes for preparation thereof and use thereof as a medicament
GB201103696D0 (en) 2011-03-04 2011-04-20 Ge Healthcare Ltd Technetium labelled peptides
GB201314936D0 (en) 2013-08-21 2013-10-02 Ge Healthcare Ltd Radiolabelling method
GB201322456D0 (en) 2013-12-18 2014-02-05 Ge Healthcare Ltd Radiotracer compositions and methods
WO2019134765A1 (en) 2018-01-08 2019-07-11 Julius-Maximilians-Universitaet Wuerzburg Sartan analogue

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0365378A (ja) * 1989-08-04 1991-03-20 Tokyo Tatsuno Co Ltd 複写伝票
US5808091A (en) * 1991-10-29 1998-09-15 Bracco International B.V. Rhenium and technetium complexes containing a hypoxia localizing moiety
JPH09165378A (ja) 1995-12-15 1997-06-24 Seitai Kinou Kenkyusho:Kk Ｎ１−［１８ｆ］フルオロベンジル複素環化合物およびそれらの製造法
ATE314097T1 (de) * 1996-10-28 2006-01-15 Amersham Health As Kontrastmittel
KR100866666B1 (ko) * 2000-04-12 2008-11-04 지이 헬스케어 에이에스 펩티드 기재 화합물
US20020049155A1 (en) * 2000-05-31 2002-04-25 Hogenkamp Henricus P.C. Cobalamin compounds useful as cardiovascular agents and as imaging agents
GB0031592D0 (en) * 2000-12-28 2001-02-07 Nycomed Amersham Plc Stabilised radiopharmaceutical compositions
GB0105224D0 (en) 2001-03-02 2001-04-18 Nycomed Amersham Plc Improved peptide-chelate conjugates
RU2303042C2 (ru) 2001-07-10 2007-07-20 Джи-И Хелткер АС Соединения на основе пептидов для направленной доставки к рецепторам интегринов
GB0116815D0 (en) * 2001-07-10 2001-08-29 Nycomed Amersham Plc Improved chelator conjugates

Also Published As

Publication number Publication date
US7919071B2 (en) 2011-04-05
ATE425770T1 (de) 2009-04-15
WO2004062568A3 (en) 2004-09-30
DE602004020049D1 (de) 2009-04-30
US20070020176A1 (en) 2007-01-25
WO2004062568A2 (en) 2004-07-29
CN1723043A (zh) 2006-01-18
EP1581262A2 (en) 2005-10-05
EP1581262B1 (en) 2009-03-18
JP2006517539A (ja) 2006-07-27

Similar Documents

Publication Publication Date Title
MXPA04000173A (es) Compuestos basados en peptidos.
NO20073039L (no) Kontrastmidler
ATE425770T1 (de) Kontrastmittel
SG149895A1 (en) Contrast agents for myocardial perfusion imaging
DK1272507T3 (da) Integrinbindende peptidderivater
WO2003105757A3 (en) METHODS AND COMPOSITIONS FOR MEDIA-DEPENDENT BINDING OF A TARGET AGENT TO A TARGET
ATE439868T1 (de) Targetingmittel für molekulare bilderzeugung
HK1097278A1 (en) Imaging agents
ATE314097T1 (de) Kontrastmittel
WO1998018497A3 (en) Contrast agents
HUP0301835A2 (hu) Kationos diagnosztikai, képalkotó és terápiás ágensek, aktivált vaszkuláris helyekkel asszociálódva
DE602005024279D1 (de) 5-substituierte-2-phenylaminobenzamide als mek-inhibitoren
GB0326546D0 (en) Inhibitor imaging agents
ATE376428T1 (de) Metallkomplexverbindungen
MX2007003518A (es) Agentes formadores de imagenes de inhibidor de metaloproteinasa.
DK1021534T3 (da) Hepatitis C-receptorprotein CD81
WO2007064661A3 (en) Bifunctional metal chelating conjugates
ATE310736T1 (de) Verbindungen zur bilddarstellung der alzheimer- krankenheit
TW200616950A (en) Synthesis of indole analogs of 1-benzyl-3-(5'-hydroxymethyl-2'-furyl)indazole (yc-1) as anti-platelet agents
NO20033115D0 (no) Peptid-baserte forbindelser
ATE480552T1 (de) Stq-peptide
WO2005049095A3 (en) Contrast agent imaging angiotensin ii receptors
ITMI20031790A1 (it) Antagonistici abiotici dell'eparina.
ATE375157T1 (de) Kombinationspräparat aus epothilone derivate und imidazotetrazinone
TW200628170A (en) Contrast agents for myocardial perfusion imaging